Pulmonary health in pregnancy

Pregnancy creates profound physiological changes in the respiratory system that can both challenge and complicate maternal health. Increased oxygen consumption, hormonal shifts, and mechanical displacement of the diaphragm alter lung function, sometimes unmasking or worsening pre-existing respiratory conditions. Pulmonary health in pregnancy is therefore an important area of clinical attention, as uncontrolled respiratory disease can impact both maternal and fetal outcomes. Asthma is the most common chronic lung condition in pregnancy, and maintaining good control with inhaled corticosteroids and bronchodilators is critical to preventing hypoxia-related complications. Pulmonary embolism represents another significant risk, requiring vigilance for early detection and the judicious use of anticoagulation tailored to maternal safety. Infectious diseases, including influenza and COVID-19, may also take on heightened severity due to immunological adaptations during pregnancy, making preventive strategies such as vaccination essential. Lifestyle modifications, particularly smoking cessation and minimizing environmental exposures, further support respiratory health. Care is optimized through multidisciplinary collaboration between pulmonologists, obstetricians, and maternal–fetal medicine specialists, ensuring that interventions balance effective disease management with fetal safety. Patient education and counseling empower expectant mothers to adhere to treatment and recognize warning symptoms early. By focusing on prevention, tailored therapy, and holistic support, pulmonary health in pregnancy underscores the dual priority of protecting maternal well-being while fostering optimal fetal development.